Diagnostic biomarkers continue to address challenges such as early and accurate diagnosis of most of the fatal diseases. Increasing advancements with extended applications of diagnostic biomarkers are only going to increase its significance in the field of diagnostics according to AMR analysts Debbie Shields and Roshan Deshmukh
The report discusses the Biomarkers Market based on diagnostic biomarker types, applications and service. The applications segment is again bifurcated into risk assessment, molecular diagnostics, disease diagnosis, drug discovery and development, drug formulation, forensic applications and others. In the report, primary focus is given to biomarkers for diagnostic applications and excludes clinical trials and research.
Diagnostic biomarker technology is likely to bring a major change in the process of drug development and medical practice as technologies are metamorphosing from traditional pathophysiology/epidemiology approach to biomarker studies such as genomics and proteomic add the analysts. Despite being a great tool for molecular diagnostics, the technology is facing challenges regarding ethical and regulatory issues as it is related to a genomic pattern of an individual which needs to be highly confidential.
Download the Sample Report @ https://www.alliedmarketresearch.com/request-sample/87
“Biomarkers Market” says that the market is likely to accrue a sum of $30.6 billion by 2020, growing at a CAGR of 16% during the forecast period, 2013 – 2020.
This report segments the global diagnostic biomarker based on diagnostic biomarker types, applications, services, and geography. The applications are further divided into risk assessment, molecular diagnostics, disease diagnosis, drug discovery and development, drug formulation, forensic applications, and others. The report particularly focuses on biomarkers for diagnostic applications. Disease diagnostic is an important application segment that is likely to accrue a sum of $6.1 billion by 2020. Nevertheless, application of diagnostic biomarkers in forensics and molecular diagnostics is growing at a rapid pace, with latter likely to witness a CAGR of 17.6% during the period, 2013 – 2020. Regarding services, the report discusses sample preparation, assay development, biomarker validation and testing, and other services.
Geographically, the report discusses the market in the regions such as North America, Europe, Asia-Pacific, and rest of the World. Asia Pacific is likely to grow at the fastest CAGR of 20.3% during the forecast period, 2013 – 2020.
The major players providing solutions in the biomarkers market are from pharmaceutical companies, government & private research institutes, academic institutes, and medical device manufacturing companies. The key players discussed in the report are Roche Diagnostic Limited (Switzerland), Siemens Healthcare (Germany), Abbott Laboratories Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Agilent Technologies Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), Aushon BioSystem Inc. (U.S.), Epistem Ltd. (U.K.), G.E. Healthcare Inc. (U.K)
KEY BENEFITS OF THE REPORT
- The report offers an assessment and ranking of the factors that favor the biomarkers market growth and those factors which act as a hindrance for the growth of the market
- Forecast period for estimating market size is from 2013 to 2020. Two historic years include 2011 and 2012
- The report identifies top investment pockets and offers an analysis of top winning strategies for diagnostic biomarker industry.
- The report analyses the various strategies adopted by some of the key companies in the industry.
- The report tracks and analyses key innovations and patents for biomarkers in the last five years
Related Reports:
Intelligent Asthma Monitoring Devices Market by Product (Wearable Asthma Monitoring Devices, and Smart Inhalers) and End User (Hospitals, Clinics, and Home Use): Global Opportunity Analysis and Industry Forecast, 2018 – 2025
Pain Management Drugs Market by Drug Class (NSAIDs, Anesthetics, Anticonvulsants, Antimigraine Agents, Antidepressants, Opioids [Tramadol, Hydrocodone, Oxycodone, and Others], and Nonnarcotic Analgesics) and Indication (Arthritic Pain, Neuropathic Pain, Cancer Pain, Chronic Back Pain, Postoperative Pain, Migraine, and Fibromyalgia) – Global Opportunity Analysis and Industry Forecast, 2017-2023
About us
Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.
Contact
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com
Your information will never be shared with any third party.